KRISTER ENGJA: Open Payments
NPI 1316519747 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 14 payments from 9 companies in 2025. Trend: 2023 $26 · 2024 $322 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $60 |
| Neurocrine BioSciences, Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Verona Pharma, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
Products named: INGREZZA, CAPLYTA, Ohtuvayre, Rybelsus, Ozempic, TRELEGY ELLIPTA, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across MI — which companies pay providers there.
